Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yvette Loeffen

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
BMJ Open|March 21, 2023
CATERPILLAR-study protocol: an assessor-blinded randomised controlled trial comparing taurolidine-citrate-heparin to heparin-only lock solutions for the prevention of central line-associated bloodstream infections in paediatric oncology patientsCeder Hildegard van den Bosch, Yvette Loeffen, Alida F W van der Steeg, et al.
Journal of Clinical Epidemiology|April 2, 2019
Expert panel diagnosis demonstrated high reproducibility as reference standard in infectious diseasesChantal B van Houten, Christiana A Naaktgeboren, Liat Ashkenazi-Hoffnung, et al.
Eclinicalmedicine|February 8, 2021
A global point prevalence survey of antimicrobial use in neonatal intensive care units: The no-more-antibiotics and resistance (NO-MAS-R) studyPavel Prusakov, Debra A Goff, Phillip S Wozniak, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
BMJ Open|March 21, 2023
CATERPILLAR-study protocol: an assessor-blinded randomised controlled trial comparing taurolidine-citrate-heparin to heparin-only lock solutions for the prevention of central line-associated bloodstream infections in paediatric oncology patientsCeder Hildegard van den Bosch, Yvette Loeffen, Alida F W van der Steeg, et al.
Journal of Clinical Epidemiology|April 2, 2019
Expert panel diagnosis demonstrated high reproducibility as reference standard in infectious diseasesChantal B van Houten, Christiana A Naaktgeboren, Liat Ashkenazi-Hoffnung, et al.
Eclinicalmedicine|February 8, 2021
A global point prevalence survey of antimicrobial use in neonatal intensive care units: The no-more-antibiotics and resistance (NO-MAS-R) studyPavel Prusakov, Debra A Goff, Phillip S Wozniak, et al.
Pageof 1